Chronic obstructive lung disease (COPD) and diffuse parenchymal lung diseases (DPLD),
including idiopathic pulmonary fibrosis (IPF) and sarcoidosis, are associated with a high …

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right
heart failure and ultimately death if untreated. The first classification of PH was proposed in …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with
pulmonary vasculopathy. Objective The purpose of this study was to determine whether …

We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate
cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung …

Pulmonary hypertension (PH) is a common complication of interstitial lung diseases (ILDs),
particularly in idiopathic pulmonary fibrosis and ILD associated with connective tissue …

Pulmonary heart disease (PHD) refers to altered structure or function of the right ventricle
occurring in association with abnormal respiratory function. Although nearly always …

Die idiopathische pulmonale Fibrose (IPF) ist eine schwerwiegende und in der Regel zum
Tod führende Erkrankung, die bisher nur unzureichend behandelt werden kann …

Pulmonary hypertension (PH) is a disease with multiple etiologies and is categorized into
five broad groups. Of these groups, pulmonary arterial hypertension (PAH) is the most …

Endocannabinoids are important regulators of organ homeostasis. Although their role in
systemic vasculature has been extensively studied, their impact on pulmonary vessels …

Background Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial
disease of the lung and has the worst prognosis of all such diseases, with a median survival …